QDigest

QDigest ·

Your Daily Dose

Diabetes, kidney function & heart failure

Back to top

Diabetes medicines that help the kidneys also reduced kidney disease progression in trial patients without diabetes.

Yes: in the combined placebo-controlled trials, people without diabetes who had chronic kidney disease or heart failure had about a one-third lower relative risk of kidney disease progression with SGLT2 inhibitors than with placebo. Serious ketoacidosis was rare and mainly occurred in people with diabetes, and no excess amputation risk was seen in the studied kidney-disease group without diabetes.

Lancet ·

Open the full explanation

Which diabetes medicines protect the heart and kidneys?

Two medicine families—SGLT-2 inhibitors, which help the kidneys pass extra sugar in urine, and GLP-1 receptor agonists, injected medicines that can reduce hunger—reduced death and protected the heart and kidneys. Finerenone, a newer kidney-protective medicine, showed similar heart and kidney benefits in people with chronic kidney disease but can cause too much potassium in the blood, sometimes needing hospital care.

BMJ ·

Open the full explanation

Hearing, cognition & Alzheimer’s

Back to top

TIA & stroke prevention

Back to top

COPD, asthma & seasonal respiratory disease

Back to top

Cancer risk, exposure & prevention

Back to top

Exercise and a normal weight did not cancel the cancer patterns tied to smoking and heavy drinking in this large Korean follow-up.

No. In an observational follow-up of 8.3 million Korean adults, people who were physically very active, had a normal body weight, but smoked and drank heavily still had higher overall cancer incidence than the healthiest non-smoking, non-drinking group. Being active or lean did not appear to erase those associations.

Cancer research and treatment ·

Open the full explanation